Gladius Capital Management’s Chemed CHE Stock Holding History

Gladius Capital Management’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-153	Closed	-$82.9K	–	392
2023 Q2	$82.9K	Sell	153 -26	-15%	-$14.2K	﹤0.01%	176
2023 Q1	$96.3K	Buy	179 +6	+3%	+$3.06K	0.01%	185
2022 Q4	$88.3K	Sell	173 -31	-15%	-$15.1K	0.01%	176
2022 Q3	$90K	Sell	204 -124	-38%	-$59.6K	﹤0.01%	181
2022 Q2	$154K	Buy	+328	New	+$160K	0.01%	167

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Gladius Capital Management's CHE Position: Q3 2023 in Review

Gladius Capital Management sold out of Chemed (CHE) in Q3 2023, closing a stake of 153 shares — an estimated $82.9K sold.

Gladius Capital Management first reported a position in CHE in Q2 2022 and held it in 5 quarters. The position peaked at $154K in Q2 2022. 457 funds tracked by Wall St. Rank hold CHE as of Q3 2023.

Gladius Capital Management reported no remaining Chemed position as of Q3 2023 after selling out during the quarter.
Gladius Capital Management sold 153 Chemed shares in Q3 2023, an estimated $82.9K.
Gladius Capital Management first reported a position in Chemed in Q2 2022 and held it in 5 quarters.
Gladius Capital Management's Chemed position peaked at $154K in Q2 2022.
457 funds tracked by Wall St. Rank held Chemed as of Q3 2023.

Based on Gladius Capital Management's 13F filing for Q3 2023, filed 10 Oct 2023.